According to Sutro Biopharma's latest financial reports the company's current earnings (TTM) are -$64.86 M. In 2022 the company made an earning of -$0.12 B a decrease over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$64.86 M | -42.79% |
2022 | -$0.12 B | 10.7% |
2021 | -$0.11 B | 265.05% |
2020 | -$28.06 M | -45.42% |
2019 | -$51.4 M | 48.65% |
2018 | -$34.58 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 184.22% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -70.78% | ๐บ๐ธ USA |